Gastroenterology

Gastroenterology

Volume 119, Issue 3, September 2000, Pages 854-865
Gastroenterology

Special Reports and Reviews
The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis

https://doi.org/10.1053/gast.2000.16507Get rights and content

Abstract

GASTROENTEROLOGY 2000;119:854-865

Section snippets

The APC/β-catenin pathway

The clinical and hereditary features of the FAP syndrome implied the existence of a single gene that regulates the formation of adenomatous polyps, the precursor for most colorectal cancers. The identification of an interstitial deletion on chromosome 5q in a patient with the Gardner's variant of FAP combined with classical linkage analysis facilitated the positional cloning of the APC gene in 1991.6, 7 The 15-exon gene encodes a multifunctional 2843–amino acid protein of 310 kilodaltons that,

The DNA mismatch repair pathway

Identification of the genes responsible for the HNPCC syndrome has led to insights into a novel mechanism of tumorigenesis in colon cancer. Mutations in five different genes (hMSH2, hMSH6, hMLH1, hPMS1, and hPMS2) have now been associated with the syndrome.43 As many as 45%–70% of HNPCC families who meet the Amsterdam criteria have mutations in one of these genes, most frequently either hMSH2 or hMLH1.44, 45 Each of the five genes encodes a protein involved in DNA mismatch repair, a complex

The TGF-β/SMAD pathway

TGF-β and related family members mediate a wide variety of biological effects, the most characteristic being its potent inhibition of proliferation.77 TGF-β initiates its broad spectrum of cellular responses through binding to the type II TGF-β receptor (TGFβRII). Binding to TGFβRII recruits and activates the type I receptor through phosphorylation of specific serine and threonine residues; signaling to the nucleus is then mediated through the so-called SMAD proteins, which are phosphorylated

Additional genetic events in colorectal tumorigenesis

KRAS is mutated in approximately 50% of colorectal tumors, and alterations in this small GTP-binding protein almost uniformly occur as activating point mutations in codons 12, 13, and to a lesser extent, 61. Among their many functions, K-ras pathways transduce signals from extracellular growth factors to regulate progression through the cell cycle and proliferation.2, 3 KRAS mutations are associated with up-regulation of DNA methyltransferase, cyclin D1, and gastrin, all of which may be

Epigenetic mechanisms in colorectal tumorigenesis

The transformation of a normal colonic epithelial cell to a malignant clone is the consequence of a complicated program in which the inappropriate activation of some genes is accompanied by the specific inactivation of others. Tumorigenesis requires that this altered program is passed on to subsequent generations of cells. Thus far, this review has focused primarily on the specific alterations in gene sequence (i.e., mutations) that fulfill these criteria. However, epigenetic mechanisms,

Implications for clinical management

Dramatic insights into the genetic basis of colon cancer have been achieved. These advances will undoubtedly have many direct applications to clinical management of patients with colorectal cancer. The feasibility of K-ras and p53 molecular analysis of stool for the diagnosis of colon cancer has already been shown and awaits further refinement.120, 121 Germline testing for the FAP and HNPCC syndromes is now commercially available and plays a valuable role in the counseling of high-risk

References (125)

  • DC Chung et al.

    DNA mismatch repair and cancer

    Gastroenterology

    (1995)
  • P Peltomaki et al.

    Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study

    Gastroenterology

    (1997)
  • HFA Vasen et al.

    Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis

    Gastroenterology

    (1996)
  • N de Wind et al.

    Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

    Cell

    (1995)
  • M Kurokowa et al.

    Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation

    Biochem Biophys Res Comm

    (1987)
  • S Markowitz et al.

    Tumor suppressor activity of the TGF-β pathway in human cancers

    Cytokine Growth Factor Rev

    (1996)
  • T Yoshitaka et al.

    Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability

    Biochem Biophys Res Commun

    (1996)
  • M Konishi et al.

    Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer

    Gastroenterology

    (1996)
  • T Fujiwara et al.

    Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences

    Am J Pathol

    (1998)
  • MR Keeton et al.

    Identification of regulatory sequences in the type I plasminogen activator inhibitor gene responsive to transforming growth factor β

    J Biol Chem

    (1991)
  • J-M Li et al.

    Transforming growth factor β activates the promoter of cyclindependent kinase inhibitor p15INK4B through an Sp1 consensus site

    J Biol Chem

    (1995)
  • MB Datto et al.

    Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter

    J Biol Chem

    (1995)
  • Y Takagi et al.

    Somatic alterations of the DPC4 gene in human colorectal cancers in vivo

    Gastroenterology

    (1996)
  • K Eppert et al.

    MADR2 maps to 18q21 and encodes a TGF-beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

    Cell

    (1996)
  • K Takaku et al.

    Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes

    Cell

    (1998)
  • RJ Guan et al.

    Association of K-ras mutations with p16 methylation in human colon cancer

    Gastroenterology

    (1999)
  • H Nakata et al.

    Oncogenic ras induces gastrin gene expression in colon cancer

    Gastroenterology

    (1998)
  • KR Cho et al.

    The DCC gene: structural analysis and mutations in colorectal carcinomas

    Genomics

    (1994)
  • JA Brockman et al.

    Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells

    Gastroenterology

    (1998)
  • LJ Ko et al.

    p53: puzzle and paradigm

    Genes Dev

    (1996)
  • I Nishisho et al.

    Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients

    Science

    (1991)
  • M Miyake et al.

    Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors

    Cancer Res

    (1994)
  • L-K Su et al.

    Association of the APC tumor suppressor protein with catenins

    Science

    (1993)
  • B Rubinfeld et al.

    Association of the APC gene product with b-catenin

    Science

    (1993)
  • J Behrens et al.

    Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta

    Science

    (1998)
  • L Spirio et al.

    Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps

    Nat Genet

    (1998)
  • Y Miyoshi et al.

    Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene

    Hum Mol Genet

    (1992)
  • SM Powell et al.

    Molecular diagnosis of familial adenomatous polyposis

    N Engl J Med

    (1993)
  • SM Powell et al.

    APC mutations occur early during colorectal tumorigenesis

    Nature

    (1992)
  • R Caspari et al.

    Familial adenomatous polyposis: desmoid tumors and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444

    Hum Mol Genet

    (1995)
  • SJ Laken et al.

    Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC

    Nat Genet

    (1997)
  • B Rubinfeld et al.

    Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly

    Science

    (1996)
  • T-C He et al.

    Identification of c-MYC as a target of the APC pathway

    Science

    (1998)
  • O Tetsu et al.

    Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

    Nature

    (1999)
  • B Mann et al.

    Target genes of beta-catenin-T-cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas

    Proc Natl Acad Sci U S A

    (1999)
  • HC Crawford et al.

    The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

    Oncogene

    (1999)
  • AB Sparks et al.

    Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer

    Cancer Res

    (1998)
  • WS Samowitz et al.

    Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas

    Cancer Res

    (1999)
  • PJ Morin et al.

    Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin of APC

    Science

    (1997)
  • FT Kolligs et al.

    Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression

    Mol Cell Biol

    (1999)
  • Cited by (360)

    • Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer

      2022, Gastrointestinal Endoscopy
      Citation Excerpt :

      Overall mortality risk and risk of adverse events associated with colonoscopy outweigh the life expectancy benefit of polypectomy for this age group.55,61,71 The primary method for CRC prevention through colonoscopy is the removal of high-risk colorectal polyps, and there is considerable lag time in the progression of a precancerous polyp to malignancy and CRC-related death.72 Thus, elderly individuals are more likely to die of natural causes than CRC, and screening provides minimal life expectancy gains beyond mean U.S. life expectancy.

    View all citing articles on Scopus

    Address requests for reprints to: Daniel C. Chung, M.D., Gastrointestinal Unit, GRJ 825, Massachusetts General Hospital, Boston, Massachusetts 02114. e-mail: [email protected].

    View full text